A topical fluorescent molecular contrast agent, PARPi-FL, can detect basal cell carcinoma through intact skin in as little as five minutes in ex vivo human tissues, according to new preclinical research published in The Journal of Nuclear Medicine. Data confirmed that PARPi-FL is non-toxic to the skin and does not cause systemic side effects, making it a potential one-stop-shop for diagnosis and management of basal cell carcinoma.
This article was originally published on MedicalXpress.com
Fostering a rewarding and fulfilling relationship is no easy task. You and your partner are only human, and, as the saying goes, you are going to make mistakes. However, learning the common relationship mistakes and […]
Microneedling is a revolutionary skincare treatment that has gained popularity in recent years due to its numerous benefits, including reducing the appearance of scars, wrinkles, and acne, and promoting collagen production. Edmonton, the bustling capital […]
For at least three decades, researchers have gathered evidence that chronic stress puts pressure on the body to constantly adjust itself to restore physiological stability. This process is known as allostatic load and it creates a cascade […]
© 2025 SimplyWell.ca